Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.
Ornstein PL, Zimmerman DM, Arnold MB, Bleisch TJ, Cantrell B, Simon R, Zarrinmayeh H, Baker SR, Gates M, Tizzano JP, Bleakman D, Mandelzys A, Jarvie KR, Ho K, Deverill M, Kamboj RK. Ornstein PL, et al. Among authors: deverill m. J Med Chem. 2000 Nov 16;43(23):4354-8. doi: 10.1021/jm0002836. J Med Chem. 2000. PMID: 11087558 No abstract available.
Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors.
Shepherd TA, Aikins JA, Bleakman D, Cantrell BE, Rearick JP, Simon RL, Smith EC, Stephenson GA, Zimmerman DM, Mandelzys A, Jarvie KR, Ho K, Deverill M, Kamboj RK. Shepherd TA, et al. Among authors: deverill m. J Med Chem. 2002 May 9;45(10):2101-11. doi: 10.1021/jm0105474. J Med Chem. 2002. PMID: 11985477
4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists.
Baker SR, Bleakman D, Ezquerra J, Ballyk BA, Deverill M, Ho K, Kamboj RK, Collado I, Domínguez C, Escribano A, Mateo AI, Pedregal C, Rubio A. Baker SR, et al. Among authors: deverill m. Bioorg Med Chem Lett. 2000 Aug 21;10(16):1807-10. doi: 10.1016/s0960-894x(00)00346-2. Bioorg Med Chem Lett. 2000. PMID: 10969973
[3H]ATPA: a high affinity ligand for GluR5 kainate receptors.
Hoo K, Legutko B, Rizkalla G, Deverill M, Hawes CR, Ellis GJ, Stensbol TB, Krogsgaard-Larsen P, Skolnick P, Bleakman D. Hoo K, et al. Among authors: deverill m. Neuropharmacology. 1999 Dec;38(12):1811-7. doi: 10.1016/s0028-3908(99)00133-1. Neuropharmacology. 1999. PMID: 10608276
LY339434, a GluR5 kainate receptor agonist.
Small B, Thomas J, Kemp M, Hoo K, Ballyk B, Deverill M, Ogden AM, Rubio A, Pedregal C, Bleakman D. Small B, et al. Among authors: deverill m. Neuropharmacology. 1998 Oct-Nov;37(10-11):1261-7. doi: 10.1016/s0028-3908(98)00122-1. Neuropharmacology. 1998. PMID: 9849663
Extra Physiotherapy in Critical Care (EPICC) Trial Protocol: a randomised controlled trial of intensive versus standard physical rehabilitation therapy in the critically ill.
Thomas K, Wright SE, Watson G, Baker C, Stafford V, Wade C, Chadwick TJ, Mansfield L, Wilkinson J, Shen J, Deverill M, Bonner S, Hugill K, Howard P, Henderson A, Roy A, Furneval J, Baudouin SV. Thomas K, et al. Among authors: deverill m. BMJ Open. 2015 May 25;5(5):e008035. doi: 10.1136/bmjopen-2015-008035. BMJ Open. 2015. PMID: 26009576 Free PMC article. Clinical Trial.
INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women.
Hilton P, Armstrong N, Brennand C, Howel D, Shen J, Bryant A, Tincello DG, Lucas MG, Buckley BS, Chapple CR, Homer T, Vale L, McColl E; INVESTIGATE studies group. Hilton P, et al. Health Technol Assess. 2015 Feb;19(15):1-273, vii-viii. doi: 10.3310/hta19150. Health Technol Assess. 2015. PMID: 25714493 Free PMC article. Clinical Trial.
37 results